Podcast: Answers to Your Questions about QbD - - BioPharm International

ADVERTISEMENT

Podcast: Answers to Your Questions about QbD


Hundreds of listeners tuned into our recent web seminar on Quality by Design, and we didn’t have time to answer all their questions. Fortunately, our speakers gathered to answer the common questions in this podcast. Listen to hear their views on questions such as:

• What are the differences in how QbD is applied to a biotech drug substance and drug product?

• Does QbD only make sense for big companies?

• How can companies make pre-approval and post approval process changes under QbD?

Click here for the full web seminar on Quality by Design.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
September 26, 2014
Author Guidelines

Click here